International Biotechnology Trust PLC Tricida, Inc. Transaction History

International Biotechnology Trust PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 14, 2020	SELL	$21.21 - $31.55 $615,090 - $914,950	-29,000 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$18.43 - $38.04 $147,440 - $304,320	-8,000 Reduced 21.62%	29,000 $635,000
Q3 2019 Nov 14, 2019	BUY	$29.87 - $42.22 $507,790 - $717,740	17,000 Added 85.0%	37,000 $1.14 Million
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $29,103 - $36,855	934 Added 4.9%	20,000 $788,000
Q1 2019 May 14, 2019	BUY	$19.96 - $38.62 $380,557 - $736,328	19,066 New	19,066 $751,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.